Alvotech ALVO
NASDAQ ALVO
$4.18 +0.19 (+4.63%)
At close: Aug 20, 2026 · 12:51 PM UTC

Alvotech (ALVO) EBITDA Margin Growth (3y) (2025 - 2026)

Alvotech (ALVO) EBITDA Margin Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Haleon 43.98 Bn 43.02 Bn - -
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn 1,129.00
3 Zoetis 31.79 Bn 30.11 Bn 1.05 Bn 2.00
4 Takeda Pharmaceutical 28.69 Bn 22.89 Bn 5.10 Bn 59.00
5 United Therapeutics 22.25 Bn 19.58 Bn 683.80 Mn -1,031.00
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn -925.00
7 Neurocrine Biosciences 15.58 Bn 15.19 Bn 935.80 Mn -46.00
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn 6,666.00
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Alvotech 1.23 Bn 1.23 Bn 5.09 Mn 62,577.00

Historic Data

Download Data
DateValue
Mar 31, 2026 62,577.00
Dec 31, 2025 330,554.00
Jun 30, 2025 376,428.00
Mar 31, 2025 1.61 Mn